Chinese Journal of New Drugs - Digital Cluster of Scitech Periodicals

Home>Journals>Chinese Journal of New Drugs

Chinese Journal of New Drugs

CSCD

ISTIC

PKU

ISSN：1003-3734

CN：11-2850/R

Frequency：Semimonthly

Website：http://www.newdrug.cn

Email：bianjibu@newdrug.cn

Postcode：100098

Articles12737

Citations124451

Funded4496

Impact Factor：2.35

Official Website

Articles

2022 No.23

Total 17 articles

Research progress of upadacitinib in the treatment of rheumatic immune diseasesWANG Wen-she, SU Yin, JIA Yuan

2289-2295

Advances in drug therapy for IgG4-related diseasesZHENG Min-min, NIE Yu-xue, ZHANG Wen

2296-2303

Considerations on the treatment of rheumatoid arthritis with Chinese patent medicine based on the combination of disease and syndromeSONG Meng-ge, JIANG Quan, GONG Xun, TANG Xiao-po, HAN Man, ZHANG Fu-yuan, XIA Cong-min, LI Da, PENG Qiu-wei

2304-2309

Advances in targeted therapeutic agents for systemic lupus erythematosusCHEN Xiao-mei, WU Xue, LUO Cai-nan, WU Li-jun

2310-2317

Treatment strategies of juvenile idiopathic arthritis in biologics eraLI Cai-feng, SHI Xin-wei, DENG Jiang-hong

2318-2322

The network pharmacological mechanism of iguratimod in the treatment of goutZENG Hui-qiong, CHEN Shuai, LU Xiao-ping, LI Xiao-juan, LIN Hui, HUANG Xia, DAI Li-ping, YAN Zhen-bo, ZHANG Hui-chang

2323-2328

Clinical application and mechanism of iguratimod in the treatment of primary Sj?gren's syndromeZOU Yao, XIAO Wei, LI Li-hua, PENG Li-juan, XIONG Ying, LI Xian-yao, GAN Hai-na, DING Jing-tao, REN Xiang

2329-2332

The effect of Qingre Lishi Huoxue treatment on bone metabolism and clinical efficacy observation in patients with active rheumatoid arthritis based on OPG/RANKL/RANK signal pathwayZHANG Di, FAN Bing, LIU Ying, JIANG Ping, LI Da-ke

2333-2337

The potential therapeutic value of iguratiomd in preclinical rheumatoid arthritisLIU Qun, SHAO Hui-jun, LI Xiao-ling, ZHU Zi-wen, WU Yue, RAN Chen-yu, TAO Jin-hui

2338-2344

A case of treatment with abatacept to rheumatoid arthritis in which multiple biologics failedWU Chun-ye, KAN Yan, KONG Chun-yu

2345-2349